Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2009 Giugno;51(2)

ULTIMO FASCICOLOPANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


Periodicità: Trimestrale

ISSN 0031-0808

Online ISSN 1827-1898


eTOC

 

Panminerva Medica 2009 Giugno;51(2)

 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 

Panminerva Medica 2009 Giugno;51(2):57-79

Aging of tissue-resident adult stem/progenitor cells and their pathological consequences

Mimeault M., Batra S. K.


 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 

Panminerva Medica 2009 Giugno;51(2):81-93

Chronic obstructive pulmonary disease and comorbidity: a review and consideration of pathophysiology

Tan S.L., Wood A.M.


 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 

Panminerva Medica 2009 Giugno;51(2):95-114

Pulmonary rehabilitation in chronic obstructive pulmonary disease

Saey D., Bernard S., Gagnon P., Laviolette L., Soicher J., Maltais F., Esgagne P., Coats V., Devost A.-A.


 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 

Panminerva Medica 2009 Giugno;51(2):115-23

Chronic obstructive pulmonary disease and its comorbidities

Panetta N. L., Krachman S., Chatila W. M.


 REVIEW 

Panminerva Medica 2009 Giugno;51(2):125-31

Oral dysphagia. An unique symptom for a wide spectrum of diseases

Campisi G., Compilato D., Di Liberto C., Di Fede O., Pizzo G., Falaschini S., Lo Muzio L., Craxi A.


 LETTERS TO THE EDITOR 

Panminerva Medica 2009 Giugno;51(2):133-4

Some patients with HCC haven’t abnornormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels

Bertino G., Ardiri A. M., Santonocito, M. M., Boemi P. M.


 LETTERS TO THE EDITOR 

Panminerva Medica 2009 Giugno;51(2):134-5

Hutchinson-Gilford progeria syndrome: clinical and genetical traits

Douglas Melo Coutinho H., Santos Falcão-Silva V., Fernandes Gonçalves G.


 LETTERS TO THE EDITOR 

Panminerva Medica 2009 Giugno;51(2):135-6

Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and Body Mass Index

Testino G., Sumberaz A., Gentile R., Ansaldi F., Borro P., Ravetti G., Icardi G.


inizio pagina